APA's 2025 annual meeting will be held in Los Angeles, CA (with virtual options) from May 17-21, 2025 with the theme, "Lifestyle for Positive Mental and Physical Health," will be the feature of a Lifestyle Psychiatry session track.

In this session, Kathleen T. Brady, MD, PhD, of the Medical University of South Carolina, will discuss the NIDA N Clinical Trials Network (CTN) study CTN-0108, “Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder,” a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a diagnosed methamphetamine or cocaine use disorder. Dr. Brady, co-Principal Investigator for CTN-0108, will present the rationale for the study, including the literature supporting the use of rTMS in stimulant use disorder, as well as the study methodology and preliminary results. Objectives: List 3 key research findings supporting the use of TMS in treating substance use disorders Describe at least 3 key elements of the methodology for a trial of TMS in treating simulant use disorders Identify at least 3 preliminary data points from the CTN-0108 study CME and CE credits available! Sponsored by the Western States Node and the Northwest and Pacific Southwest ATTCs. About the presenter: Kathleen T. Brady, M.D., Ph.D. Distinguished University Professor Director, South Carolina Clinical and Translational Research Institute Medical University of South Carolina Dr. Brady is an experienced clinical and translational researcher and has been conducting scientific investigations and clinical work in the field of addictions and psychiatric disorders for over 40 years. Her focus is on pharmacotherapy and neurobiology of addictions, comorbid psychiatric disorders and gender differences in addictions.  She has received numerous federal research grants and has published over 400 peer-reviewed journal articles and edited/co-edited 10 books.  She is the former Vice President for Research at the Medical University of South Carolina.  She has been a member of AAAP for over 25 years  and has served at the President of the Association for Medical Education and Research in Substance Use Disorders (AMERSA), the American Academy of Addiction Psychiatry (AAAP) and is the immediate past president of International Society of Addiction Medicine (ISAM).